...
首页> 外文期刊>Physical and Engineering Sciences in Medicine >Analysis of normal lung irradiation in radiosurgery treatments: a comparison of lung optimized treatment (LOT) on cyberknife, 4D target volume on helical tomotherapy, and DIBH on linear accelerator
【24h】

Analysis of normal lung irradiation in radiosurgery treatments: a comparison of lung optimized treatment (LOT) on cyberknife, 4D target volume on helical tomotherapy, and DIBH on linear accelerator

机译:正常的肺分析辐照放射外科治疗:肺癌的比较优化射波刀治疗(很多),4 d在螺旋tomotherapy目标卷,DIBH直线加速器

获取原文
获取原文并翻译 | 示例
           

摘要

Quantitative retrospective analysis of the normal lung irradiation due to the variations of the ITV volume based on the techniques used for upper lobe (UL), mid lobe (ML), and lower lobe (LL) lung tumours when used with 2-view, 1-view, 0-view based LOT technique on Cyberknife, AveIP on Helical Tomotherapy, and DIBH on VMAT systems. In the treatment of lung tumours, patients medically inoperable or those who are unwilling to undergo surgery have the option to be treated using radiation therapy. There are many motion control techniques available for the treatment of the moving target, such as movement encompassment, respiratory gating, breath-hold, motion reduction, and tumour monitoring. ITV generation is dependent on technique and hence the volume of the PTVs will differ based on the technique used. This study aimed to determine the influence of these ITVs on the irradiated normal lung volume for UL, ML, and LL lung tumours for 23 patients. The mean difference in the PTV volumes generated with the 0-view technique was significant with that of 2-view and DIBH techniques (p-value 0.04). The mean difference in the PTV volumes generated by 2-view and DIBH was small for UL, ML, and LL tumours. V-5 of the combined lung with the 0-view method was 5% compared to the 2-view method for UL tumours (p-value = 0.04) and the same was 9.5%, and 16.8% for ML and LL tumours (p-value 0.04). In contrast to all other techniques, lung volume parameters V-5, V-10, V-20,V- and V-30 for the 0-view technology were consistently higher irrespective of the tumour location in the lung. The observed maximum mean lung dose (MLD) was 6.2 Gy +/- 2.7 Gy with the 0-view technique and the minimum was 3.85 Gy +/- 1.75 Gy with the DIBH technique. The difference in MLD between DIBH and 2-view was negligible (p-value = 0.67). The MLD increased for LL tumours from 4 Gy to 6.5 Gy from the 2-view to 0-view technique (p-value = 0.009). There was a significant increase in MLD for LL tumours with the 0-view technique compared to AveIP (1.9 Gy, p-value = 0.04) and DIBH (2.0 Gy, p-value = 0.003) technique. For ML and UL tumours, except for 0-view and 1-view, the difference in the MLD between the rest of the methods was not significant (p-value 0.11). In the treatment of lung tumour patients with SBRT, this study has demonstrated 2-view with Cyberknife and DIBH with VMAT treatment techniques have optimal normal lung tissue sparing. There was a significant increase in the average lung volume receiving 5%,10%, 20%, and 30% dose when comparing the 1-view, 0-view, AveIP, and DIBH techniques to the 2-view technique. However, DIBH with VMAT was dosimetrically advantageous for ML and LL tumours, while providing significantly shorter treatment times than any other technique studied.
机译:定量的回顾性分析正常肺辐照ITV的变化造成的基于使用的技术上的体积叶(UL),中部叶(ML),和更低的叶(LL)肺肿瘤一起使用时两幅,1视图,AveIP 0-view很多技术基于射波刀在螺旋Tomotherapy, DIBH VMAT系统。治疗肺肿瘤患者临床上不能或不愿意的人接受手术治疗可以选择使用放射治疗。控制技术用于治疗移动的目标,比如运动环绕,呼吸门控,屏息,运动减少,肿瘤监测。代,因此依赖于技术的体积PTVs将基于不同技术使用。这些公司在辐照的影响正常肺容积UL,毫升,将肺肿瘤23个病人。卷与0-view技术生成的重要的两幅和DIBH技术(假定值& 由两幅差异PTV卷和UL DIBH很小,毫升,肿瘤。V-5 0-view联合肺的方法5% UL的两幅方法相比呢肿瘤(p = 0.04)和相同的为9.5%,16.8%,毫升和LL肿瘤(假定值& 0.04)。体积参数V-5 V-10 V-20, V -和V-300-view技术都高无论在肺肿瘤的位置。观察到的最大平均肺剂量(MLD)是6.2Gy + / - 2.7 Gy 0-view技术和最低是3.85 Gy DIBH + / - 1.75 Gy技术。两幅是微不足道的(p = 0.67)。增加肿瘤从4 Gy 6.5 Gy的两幅0-view技术(p = 0.009)。有一个显著增加MLD噢肿瘤与0-view技术相比AveIP (1.9 Gy,假定值= 0.04)和DIBH (2.0 Gy,假定值= 0.003)技术。肿瘤,除了0-view和1视图差异之间的MLD的其余部分方法不显著(假定值比;治疗肺肿瘤患者SBRT,这项研究表明两幅射波刀和DIBH VMAT治疗技术优化正常肺组织保留。平均肺容积收到5%,10%,20%,30%的剂量比较1视图时,0-view,两幅AveIP和DIBH技术技术。毫升和LL dosimetrically有利肿瘤,同时提供显著缩短治疗时间比其他任何技术研究。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号